GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 29 filers reported holding GEMPHIRE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $67,000 | -52.5% | 176,544 | +1.4% | 0.00% | 0.0% |
Q2 2019 | $141,000 | -29.1% | 174,044 | +0.6% | 0.00% | -50.0% |
Q1 2019 | $199,000 | +43.2% | 173,044 | +0.6% | 0.00% | 0.0% |
Q4 2018 | $139,000 | -60.7% | 172,044 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $354,000 | -79.2% | 172,044 | +2.8% | 0.00% | -83.3% |
Q2 2018 | $1,705,000 | +56.9% | 167,364 | +0.2% | 0.02% | +50.0% |
Q1 2018 | $1,087,000 | -13.9% | 166,964 | +5.0% | 0.01% | -20.0% |
Q4 2017 | $1,263,000 | -16.9% | 158,964 | -0.6% | 0.02% | -25.0% |
Q3 2017 | $1,520,000 | -22.4% | 159,964 | +4.5% | 0.02% | -31.0% |
Q2 2017 | $1,959,000 | +23.9% | 153,064 | +1.7% | 0.03% | +7.4% |
Q1 2017 | $1,581,000 | – | 150,564 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Exchange Capital Management, Inc. | 532,381 | $5,425,000 | 1.61% |
NORTHPOINTE CAPITAL LLC | 698,802 | $7,121,000 | 0.94% |
Cormorant Asset Management, LP | 1,041,635 | $10,614,000 | 0.78% |
Stonepine Capital Management, LLC | 103,000 | $1,050,000 | 0.64% |
Wilks Brothers, LLC | 158,547 | $1,616,000 | 0.17% |
GM Advisory Group, LLC | 43,335 | $442,000 | 0.13% |
Telemetry Investments, L.L.C. | 15,488 | $158,000 | 0.06% |
JBF Capital, Inc. | 20,000 | $204,000 | 0.03% |
BAMCO INC /NY/ | 469,860 | $4,788,000 | 0.02% |
Cambridge Investment Research Advisors, Inc. | 167,364 | $1,705,000 | 0.02% |